Bonk (SHOT) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
2 Dec, 2025Executive summary
Annual meeting scheduled for December 22, 2025, to be held virtually, with record date set as November 20, 2025.
Stockholders will vote on re-election of seven directors and ratification of the independent auditor for 2025.
Voting rights are allocated among common and preferred stockholders, with significant voting power held by Series A, B, and C Preferred Stock.
Proxy materials and annual report are available online; proxies can be submitted by mail, phone, or online.
Voting matters and shareholder proposals
Proposal 1: Re-election of seven directors to serve until the 2026 annual meeting or earlier resignation/removal.
Proposal 2: Ratification of M & K CPAS, PLLC as independent registered public accounting firm for fiscal year ending December 31, 2025.
Board recommends voting “FOR” all director nominees and auditor ratification.
Shareholder proposals for the 2026 meeting must be submitted by February 13, 2026.
Board of directors and corporate governance
Board consists of seven directors, with four meeting Nasdaq independence standards.
Three standing committees: Audit, Compensation, and Nominating & Corporate Governance, each with formal charters.
Board held five meetings in 2024; all directors attended at least 90% of meetings.
Board leadership structure separates CEO and Chairman roles; code of ethics in place.
Latest events from Bonk
- Amended registration for public stock offering, led by CEO Jarrett Boon, with $113K in expenses.SHOT
Registration Filing28 Jan 2026 - Patented dietary supplement business registers shares for resale, funding R&D and growth.SHOT
Registration Filing16 Dec 2025 - Registering 1.9M shares for resale; proceeds from warrants fund R&D and working capital.SHOT
Registration Filing16 Dec 2025 - Patented dietary supplement targets alcohol metabolism, with shares registered for resale on NASDAQ.SHOT
Registration Filing16 Dec 2025 - Registering 1.9M shares for resale, with proceeds from options and warrants funding R&D.SHOT
Registration Filing16 Dec 2025 - Registers 31.8M shares for resale after a strategic pivot to digital assets and DeFi.SHOT
Registration Filing10 Dec 2025 - Safety Shot will acquire Yerbaé, with shareholders exchanging shares at a 0.2918 ratio, pending approvals.SHOT
Proxy Filing2 Dec 2025 - Safety Shot and Yerbaé propose a merger, with Yerbaé shareholders to receive 0.2918 Safety Shot shares per share.SHOT
Proxy Filing2 Dec 2025 - Safety Shot to acquire Yerbaé, forming a wellness beverage leader with $12M in 2023 revenue.SHOT
Proxy Filing2 Dec 2025